Dr. Reddy's Launches Levocetirizine Tablets in US

Dr. Reddy's Laboratories RDY has launched Levocetirizine tablets (5mg), a bioequivalent generic version of Xyzal® tablets in the US market. The United States Food & Drug Administration (USFDA) approved Dr. Reddy's ANDA for Levocetirizine tablets on February 24, 2011. Levocetirizine had total U.S. sales of approximately $238 million for the twelve months ending September 30, 2010 according to IMS Health. Dr. Reddy's Levocetirizine tablets are available in 90 count bottles.